Pioneer FDA Monday, August 13, 2018 0.00 Neutral

FDA Approves FEXOFENADINE HYDROCHLORIDE — Pioneer Life Sciences, LLC

# FDA Approves Generic Fexofenadine Hydrochloride for Pioneer Life Sciences Pioneer Life Sciences, LLC received FDA approval for its generic fexofenadine hydrochloride oral formulation, expanding the competitive landscape in the over-the-counter antihistamine market and potentially pressuring branded alternatives through increased price competition. The approval of this widely-used allergy medication is expected to enhance market access and affordability for consumers while offering Pioneer Life Sciences a foothold in the established antihistamine segment.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day